Alpine Global Management’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-25,000
Closed -$622K – 262
2026
Q2
$622K Buy
+25,000
New +$585K 0.1% 94
2026
Q1
– Sell
-15,773
Closed -$177K – 243
2025
Q4
$177K Buy
+15,773
New +$180K 0.04% 214

Other funds holding AVNS

Alpine Global Management's AVNS Position: Q3 2026 in Review

Alpine Global Management sold out of Avanos Medical (AVNS) in Q3 2026, closing a stake of 25,000 shares — an estimated $622K sold.

Alpine Global Management first reported a position in AVNS in Q4 2025 and held it in 2 quarters. The position peaked at $622K in Q2 2026. 3 funds tracked by Wall St. Rank hold AVNS as of Q3 2026.

  • Alpine Global Management reported no remaining Avanos Medical position as of Q3 2026 after selling out during the quarter.
  • Alpine Global Management sold 25,000 Avanos Medical shares in Q3 2026, an estimated $622K.
  • Alpine Global Management first reported a position in Avanos Medical in Q4 2025 and held it in 2 quarters.
  • Alpine Global Management's Avanos Medical position peaked at $622K in Q2 2026.
  • 3 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2026.

Based on Alpine Global Management's 13F filing for Q3 2026, filed 16 Nov 2026.